BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 1,300 shares, a growth of 18.2% from the October 15th total of 1,100 shares. Based on an average trading volume of 1,700 shares, the days-to-cover ratio is currently 0.8 days.

BioSyent Stock Down 1.3 %

BioSyent stock traded down $0.10 during midday trading on Friday, hitting $7.83. 4,212 shares of the company’s stock were exchanged, compared to its average volume of 2,109. BioSyent has a 12 month low of $5.83 and a 12 month high of $8.90. The firm has a 50-day moving average of $8.00 and a two-hundred day moving average of $7.42.

BioSyent Increases Dividend

The company also recently declared a dividend, which was paid on Sunday, September 15th. Shareholders of record on Thursday, September 5th were given a dividend of $0.0334 per share. This represents a dividend yield of 1.72%. This is a positive change from BioSyent’s previous dividend of $0.03. The ex-dividend date of this dividend was Wednesday, September 4th.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.